Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02083185
Brief Title: A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer

First Submitted : March 6, 2014
First Submitted that Met QC Criteria : March 7, 2014
First Posted : March 11, 2014 (Estimate)

Results First Submitted : February 1, 2018
Results First Submitted that Met QC Criteria : April 9, 2018
Results First Posted : May 9, 2018

Certification/Extension First Submitted : May 6, 2016
Certification/Extension First Submitted that Met QC Criteria : May 6, 2016
Certification/Extension First Posted : June 3, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 9, 2018
Last Update Posted : May 9, 2018